← Eichor
Study identifier: NCT07411118 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

RCT of EFTR Versus STER for GIST Treatment

Condition: Small Size Gastrointestinal Stromal Tumors · GIST  ·  Sponsor: Chinese University of Hong Kong

PhaseNA
Planned participants136
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Endoscopic resection has been increasing utilized as the treatment for small size gastrointestinal stromal tumors (GIST), of which the best resection method has not been identified. We aim to compare the outcomes of endoscopic full thickness resection (EFTR) versus submucosal tunnelling endoscopic resection (STER) for clinical small gastric GIST. We hypothesize that EFTR could achieve better complete margin negative resection than STER without increase in adverse event. This is an international multi-center double blinded randomized controlled trial involving four high volume centers from Hong Kong, mainland China, India and Japan. Adult patients with clinical 1.0-3.Scm gastric GIST undergoing endoscopic resection would be recruited. Patients would be randomized to undergo EFTR (intervention) or STER (Control) by expert endoscopists under general anaesthesia according to well published methods.

This description comes directly from the study's public registry record.

Talk to the study team

Hon Chi Yip  ·  +852 3505 2956  ·  hcyip@surgery.cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (4)

Department of Gastroenterology, Zhongshan Hospital of Fudan UniversityShanghai, ChinaNot Yet Recruiting
Department of Surgery, Faculty of Medicine, the Chinese University of Hong KongHong Kong, Hong KongRecruiting
Asian Institute of GastroenterologyHyderabad, IndiaNot Yet Recruiting
Osaka International Cancer InstituteOsaka, JapanNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07411118